About VisualDx

Version: 6.13.1083    (Build 6410)

© 2000-2010 Logical Images, Inc. All rights reserved. Patent pending.

VisualDx is a registered trademark of Logical Images, Inc.


Medical Disclaimer:

The information contained in this software package is intended to be an adjunct to traditional medical information sources. This software is not intended to be a substitute for professional medical judgment.

The practice of medicine is a complex process that involves the synthesis of information from a multiplicity of sources. The information contained in this software delivers similar information to that of a textbook and is but one of the sources that may be used in establishing a diagnosis for a patient. Logical Images, Inc., accepts no responsibility for the correctness of any diagnosis based in whole or in part upon the use of this software.

This software is provided to make access to referential medical information faster and to make the search for that medical information available through multiple search paths.



Image Contributors:
Carl Allen DDS, MSD
Brandon Ayres MD
Robert Baran MD
Donald Belsito MD
William Bonnez MD
Sarah Brenner MD
Robert Brodell MD
Sean P. Bush, MD, FACEP
Jeffrey Callen MD
Scott Camazine, MD
Michael Cardwell
Robert Chalmers MD, MRCP, FRCP
Flavio Ciferri MD
Noah Craft MD, PhD
Charles Crutchfield III MD
Bart J. Currie MBBS, FRACP, DTM&H
C. Ralph Daniel III MD
Ncoza Dlova MD
James Earls MD
David Elpern MD
Nancy Esterly MD
Stephen Estes MD
E. Dale Everett MD
Janet Fairley MD
David Feingold MD
Benjamin Fisher MD
David Foster MD, MPH
Michael Franzblau MD
Vincent Fulginiti MD
Lowell Goldsmith MD, MPH
Bernardo Gontijo MD, PhD
Kenneth Greer MD
Alan Gruber MD
Vidal Haddad MSC, PhD, MD
John Harvey
Peter W. Heald, MD
Li-Yang Hsu MD
Shahbaz A. Janjua MD
Robert Kalb MD
Henry Kempe MD
Loren Ketai MD
Sidney Klaus MD
Carl Krucke
Sue Lewis-Jones FRCP, FRCPCH
Edith Lederman MD
Taisheng Li MD
Jason Maguire MD
Mark Malek, MD, MPH
Ricardo Mandojana MD
Lynne Margesson MD
Karen McKoy MD
Thomas McMeekin MD
Mary Gail Mercurio MD
Larry E. Millikan MD
Dean Morrell, MD
Samuel Moschella MD
Taimor Nawaz MD
Vic Newcomer MD
Steven Oberlender MD, PhD
Maria Teresa Ochoa MD
Art Papier MD
Lawrence Parish MD
Robert Penne MD
Christopher J. Rapuano MD
Sireesha Reddy, MD
Angela Restrepo MD, PhD
Bertrand Richert MD, PhD
Daniel Sexton MD
Paul K. Shitabata, MD
Tor Shwayder, MD, FAAP, FAAD
Elaine Siegfried MD
Mary J. Spencer, MD, FAAP
Sarah Stein MD
William Van Stoecker MD
Frances J. Storrs MD
Jenny Valverde MD
Susan Voci MD
Lisa Wallin ANP, FCCWS
George Watt MD
Sally-Ann Whelan, MS, NP, CWOCN
Jan Willems MD, PhD
Karen Wiss MD
Sook-Bin Woo MS, DMD, MMSc

Am. Journal of Trop. Med & Hygiene
Armed Forces Pest Management Board
Blackwell Publishing
Bugwood Network
Centers For Disease Control and Prevention
International Atomic Energy Agency
Massachusetts Medical Society
Radiological Society of North America
Wikipedia
World Health Organization
Contact Us
Support/Customer Service:
Please call Logical Images, Inc., at 800-357-7611 (US only) or e-mail us at support@logicalimages.com.
Sales:
Please call Logical Images, Inc., at 800-357-7611 (US only) or send e-mail to sales@logicalimages.com.
Copyright Notice

Images, Text and Knowledge contained within VisualDx are copyright protected and should not be copied, pasted, used in presentations, printed or used in any other manner than viewing within VisualDx.

Logical Images respects the intellectual property of others, and we ask our users to do the same. The images, text, design and database of VisualDx are protected by copyright and the intellectual property laws of the United States and/or other countries. It is Logical Images's policy, in appropriate circumstances and at its discretion, to disable and/or terminate the accounts of users who infringe our copyright and the copyright of our image contributors.

Clinical Scenario
Male Adult Anogenital
Last Updated: 02/22/2010
110.3 – Dermatophytosis of the groin and perianal area
Tinea cruris (jock itch) is a superficial fungal infection of the skin most commonly caused by Trichophyton rubrum or other dermatophytes. Tinea cruris manifests as a symmetric erythematous rash in the inner thighs and the crural folds. It rarely spreads to the penis, but if it does, it will be found only at the base of the penis. It is often spread to the groin from fungal infection of the feet (tinea pedis).

Tinea cruris is usually associated with pruritus and is more common in postpubertal males. People at higher risk include those who have diabetes mellitus, are obese, recently visited a tropical climate, wear tight-fitting or wet clothes (including bathing suits) for extended periods, share clothing with others, or participate in sports.
Look for circular or annular, red, scaly plaques extending from the inguinal creases, down the medial thigh, and all around the pubic area and buttocks. The plaques usually have a sharply demarcated edge and a central clearing. Plaques are described as having an active border, meaning that the advancing edge of the plaque has prominent scale containing fungal hyphae. The central clearing of the elevated patches or plaques leads to the appearance of annular lesions and, thus, the description "ringworm" (a misnomer). The area affected may be moist and exudative in acute infections and dry in chronic infections.
In fungal lesions that have been treated with topical steroids, the redness can be absent, and minimal scaling may be present while the lesion is loaded with fungi. If the scraping is negative in a lesion that has not been treated, the lesion is probably not fungal in etiology.
Scrape the scaly, active border with a scalpel blade or edge of a glass slide. Collect scale on a slide and coverslip. Direct a drop of 10% KOH (potassium hydroxide) to the edge of the coverslip, or put a drop of the KOH on the scales before covering with the coverslip. Wait for about 5 minutes, then examine with the microscope. Observe for branching or curving fungal hyphae, which cross the keratin cell borders.
Treat all active areas of infection simultaneously to prevent reinfection of the groin from other body sites. Treat clinically affected areas and a 2 cm margin of healthy-appearing skin, and continue to treat for 1 week after clinical resolution. Also advise drying the inguinal folds completely after bathing. Explain to the patient that permanent cure is rare, but proper treatment results in excellent control that will, however, require periodic re-treatment.
Limited, localized disease should be treated topically. Allylamines (eg, terbinafine, naftifine) and imidazoles (eg, clotrimazole) are the mainstays of therapy. Allylamines may require shorter courses, but imidazoles are less expensive. 
 
Use topical antifungals for 1–6 weeks, based on clinical response:
  • Terbinafine 1% cream or spray – apply once to twice daily
  • Clotrimazole 1% cream – apply twice daily
  • Econazole 1% cream – apply once to twice daily
  • Oxiconazole 1% cream – apply twice daily
  • Ciclopirox  0.77% cream, gel, or lotion – apply twice daily
  • Ketoconazole 2% cream – apply once to twice daily
  • Miconazole 2% cream – apply twice daily
  • Naftifine 1% cream – apply once to twice daily
  • Butenafine 1% cream – apply once to twice daily
Topical corticosteroids by themselves or in combination with antifungals are generally not indicated and are absolutely contraindicated in immunosuppressed patients. Use of corticosteroid-antifungal combinations in cases of diagnostic uncertainty may lead to persistent fungal infections and is not recommended.
 
Extensive disease, particularly when other body parts are involved, may require weeks of oral antifungal agents:
  • Terbinafine 250 mg once a day for 2–4 weeks
  • Itraconazole 100–200 mg twice a day for 1 week
  • Fluconazole 150–300 mg once a week for 2–4 weeks
  • Griseofulvin ultramicrosize 5 mg/kg/day for 4–8 weeks (generally reserved for severe cases)
Systemic antifungals are contraindicated in patients with liver disease; monitoring of liver enzymes is generally recommended.
Gupta AK, Cooper EA. Update in antifungal therapy of dermatophytosis. Mycopathologia. 2008 Nov-Dec;166(5-6):353-67. PubMed Id: 18478357

Verma S, Heffernan MP. Superficial fungal infection: Dermatophytosis, Onychomycosis, Tinea Nigra, Piedra. In: Fitzpatrick TB, Wolff K, eds. Fitzpatrick's Dermatology in General Medicine. 7th ed. New York, NY: McGraw-Hill; 2008:1815.

Kyle AA, Dahl MV. Topical therapy for fungal infections. Am J Clin Dermatol. 2004;5(6):443-51. PubMed Id: 15663341

Gupta AK, Chaudhry M, Elewski B. Tinea corporis, tinea cruris, tinea nigra, and piedra. Dermatol Clin. 2003 Jul;21(3):395-400, v. PubMed Id: 12956194

Lebwohl M, Elewski B, Eisen D, Savin RC. Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris. Cutis. 2001 Mar;67(3):261-6. PubMed Id: 11270304

van Heerden JS, Vismer HF. Tinea corporis/cruris: new treatment options. Dermatology. 1997;194 Suppl 1:14-8. PubMed Id: 9154395

Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hardinsky MK, Lewis CW, Pariser DM, Skouge JW, Webster SB, Whitaker DC, Butler B, Lowery BJ, Elewski BE, Elgart ML, Jacobs PH, Lesher JL, Scher RK. Guidelines of care for superficial mycotic infections of the skin: tinea corporis, tinea cruris, tinea faciei, tinea manuum, and tinea pedis. Guidelines/Outcomes Committee. American Academy of Dermatology. J Am Acad Dermatol. 1996 Feb;34(2 Pt 1):282-6. PubMed Id: 8642094
Appearance
No Acute Distress

Body Location
Buttocks
Crural or Inguinal Fold
Leg
Suprapubic/Mons Pubis
Thigh

Distribution
Bilateral
Intertriginous
Widespread Male Genital

Lesion
Scale Fine
Scaly Plaque

Occupations
Military

Signs and Symptoms
No Fever (Afebrile, Apyrexial)
Obesity
Pruritus (Itching)

Temporal
Developed Acutely Over Days to Weeks
Developed Steadily Over Weeks to Months

Medical History
Diabetes Mellitus
Diabetes Mellitus Type I
Diabetes Mellitus Type II

Authors
Lowell A. Goldsmith MD, MPH, Benjamin K. Fisher MD